#AAIC #NeuroscienceNext #AAIC2027 #ThailandHub #AlzheimersResearch #DementiaResearch #ADRD #Neuroscience #Bangkok #Thailand #ISTAART

What drives microglial aging in the brain?
Research pinpoints SLC16A3 and P2RY13 as core molecular aging drivers, validated in human tissue. Aβ phagocytosis assays conducted using rPeptide's Beta-Amyloid (1-42) Aggregation Kit. 🧠
We are excited to welcome Angela Gomez-Arboledas, PhD, to the CureAlz team as Senior Director, Grant Management. Angela will play a lead role in supporting CureAlz’s grant portfolio and identifying the most promising research ideas for funding. Welcome, Angela! #AlzheimersResearch
Can J147 Turn Intimidated Subjects Into Confident Leaders?
Vascular leakage trial:
Source: pmc.ncbi.nlm.nih.gov/articles/PMC...
Alzheimer's memory study:
Source: pmc.ncbi.nlm.nih.gov/articles/PMC...
#BrainHealth #Neuroplasticity #CognitiveEnhancement #AlzheimersResearch #MemoryEnhancement
"If we get at least 10 people listening... my mom and everyone else who interviewed, I think we're OK." 😆
Host Shea Andrews, PhD, and Episode 2 guest Miranda Good, PhD, joked about their audience before the podcast even launched.
Help us prove them wrong.
Do sex differences in Alzheimer's change as pathology progresses? Our new study analyzes over 1000 donors across transcriptomics & proteomics and shows that sex acts as a large, stable offset rather than a disease modifier: link.springer.com/article/10.1... #AlzheimersResearch #SexDifferences
A new Mount Sinai study in Neuron links genetic ancestry and DNA structure in the tau gene region to differences in gene expression and tau RNA forms. These patterns vary by brain region and cell type. www.cell.com/neuron/fullt... #Alzheimers #AlzheimersResearch #Genomics @sinaibrain.bsky.social
Some of our past conversations remain just as relevant today.
Dr. Buckley discusses women's brain health and Alzheimer's disease, exploring how menopause, hormones, and genetics may influence risk and resilience.
#AlzheimersResearch is challenging. AD involves a complex network of interconnected pathways, each worthy of exploration. Researchers continually innovate, collaborate, and persist in pursuit of a cure.
Together, we continue the climb, one step at a time.
There's still time to explore our collection of Alzheimer's and brain health research. Featuring articles, reviews, and expert perspective.
Read the collection: https://ow.ly/c2he50ZG1s6
#AlzheimersAwarenessMonth #AlzheimersResearch #DementiaResearch
Walk for Alzheimer's: Boost Brain Health, Support Patients! #shorts: Join the movement! A scenic walk fuels physical activity and supports crucial Alzheimer's research. Discover the power of daily exercise and employee volunteering in our community. #AlzheimersResearch #CommunityEvent #GetActive…
The Holy Grail of Brain Repair: Which BDNF Booster Wins?
Analyze how Semax and elite BDNF peptides stimulate rapid neuroplasticity in research models for animals.
#peptdes #AlzheimersResearch #autismresearch #parkinsons #alsresearch
Science is built through collaboration, connection, and shared discovery.
"Science is a collaborative endeavor. You don't have to go at it alone."
Hear more career advice from Dr. Malú Gámez Tansey on #TheCCADExchange. Full episode drops tomorrow.
How can Alzheimer’s blood-based biomarkers be used in primary care?
Michelle M. Mielke, PhD, discusses evidence from a large U.S. health system and clinical pathways Sept. 28, 10–11 a.m. PT. Attend at UCSF or virtually.
register 👉️ bit.ly/4dhColS
Our water-soluble CNO dihydrochloride has been cited in the Journal of the @alzassociation 🙌
Kolling et al used our products to find that increased excitability of serotonergic/glutamatergic neurons promote tau accumulation 🔬
Learn more: ow.ly/IwO450ZQ1XN
Older adults with mild cognitive impairment and sleep problems who took 5,000+ IU of vitamin D daily scored 13% higher on cognitive assessments than those who took none.
How can Alzheimer’s blood-based biomarkers be used in primary care?
Michelle M. Mielke, PhD, discusses evidence from a large U.S. health system and clinical pathways Sept. 28, 10–11 a.m. PT. Attend at UCSF or virtually.
register 👉️ bit.ly/4dhColS
Could circadian clock disruption drive sex-specific Tau pathology?
Research shows microglial REV-ERBα deletion impairs Tau clearance and worsens tauopathy only in males, using rPeptide's FITC-labeled Tau-441. 🧠
Earlier this year, King’s researchers identified a previously unknown form of cell death in Alzheimer's, called karyoptosis. 🧠
The discovery could open up new avenues for future treatment development.
🔗 Read more: www.kcl.ac.uk/news/new-mec...
@alzheimersresearchuk.org
#AlzheimersResearch